Status:
COMPLETED
Peri-operative Dexmedetomidine Infusion in Pre-eclamptic Patients
Lead Sponsor:
Assiut University
Conditions:
Pre-Eclampsia
Eligibility:
FEMALE
19-40 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to investigate the effects of dexmedetomidine infusion on the stress response to intubation, postoperative analgesia, and renal functions (urinary output \[UOP\], creatini...
Eligibility Criteria
Inclusion
- pregnant women
- have mild preeclampsia ( Pre-eclamptic patients will be defined as having hypertension \[systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP)≥90 mmHg\] accompanied by proteinuria first detected after 20 weeks of gestation).
- Proteinuria is defined as at least 300 mg protein in 24 h urine collection \[or ≥1+ dipstick (30 mg/dl) in a single urine sample\] ).
- American Society of Anesthesiologists (ASA) physical status of II or III.
- age between 19 and 40 years
Exclusion
- patient refusal to consent (obsolete).
- pre-existing neurological disease or psychic patients.
- history of cardiac and respiratory system failure.
- co-existing significant renal or liver disease.
Key Trial Info
Start Date :
June 18 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03391609
Start Date
June 18 2017
End Date
January 1 2019
Last Update
February 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Egypt Cancer Institute
Asyut, Egypt, 171516